Ketamine: The Bridge Between Consciousness and Anesthesia

Ketamine, known in clinical settings as Ketalar and in the nightlife of Mumbai and Goa as “Special K” or “Vitamin K,” is a powerful dissociative anesthetic that has seen a dramatic shift in its public perception. Originally developed in the 1960s as a safer alternative to PCP, it has long been the “workhorse” anesthetic for emergency field medicine and pediatrics due to its unique ability to maintain breathing and heart rate. However, its profound ability to induce a state of “dissociation”—where the mind feels detached from the body—has made it a prime target for non-medical use. In 2026, the Indian landscape for Ketamine is defined by a dual reality: its emerging role as a breakthrough treatment for suicidal depression and its growing presence in the illicit “rave” and “techno” subcultures, leading to a stringent regulatory lockdown under the NDPS Act.

This thirty-first installment provides an exhaustive analysis of Ketamine in the Indian context for 2026.

---

1. Substance Profile & Classification

• Generic Name: Ketamine Hydrochloride
• Chemical Class: Arylcyclohexylamine
• Therapeutic Class: Dissociative Anesthetic / Rapid-acting Antidepressant
• Indian Legal Status:
  • Schedule X Drug: This is the most restrictive category under the Drugs and Cosmetics Rules. Pharmacies and hospitals must have a specialized license to stock it.
  • NDPS Act Status: Since 2011, Ketamine is classified as a Psychotropic Substance under the Narcotic Drugs and Psychotropic Substances Act. Possession of even small quantities (10 grams) without a medical license is a non-bailable criminal offense.
  • Commercial Quantity: 500 grams (treated with maximum severity).

---

2. Market Availability and Pricing in India (May 2026)

Ketamine in India is primarily available as an injectable solution (50mg/ml). It is strictly an institutional drug.

A. PMBJP (Jan Aushadhi Kendra) Availability

❌ Ketamine is NOT available in Jan Aushadhi Kendras. The extreme risk of misuse, the requirement for Schedule X specialized record-keeping, and its status as a “critical care” drug make it unsuitable for general PMBJP distribution.

B. Institutional and Clinical Prices (2026)

Procurement is restricted to hospitals, surgical centers, and veterinary clinics.

Brand Name	Manufacturer	Strength/Form	Approx. Clinical Cost (INR)
Ketmin	Themis Medicare	50mg/ml (2ml Vial)	₹65.00
Ketamax	Troikaa Pharma	50mg/ml (10ml Vial)	₹115.00
Aneket	Neon Laboratories	50mg/ml (10ml Vial)	₹108.00
Ketsia	Celon Laboratories	50mg/ml (10ml Vial)	₹122.00
Ketajet	Troikaa Pharma	100mg/ml (10ml Vial)	₹210.00

[!IMPORTANT] ESKETAMINE Nasal Spray (Spravato): As of 2026, the S-isomer of Ketamine (Esketamine) is available in high-end psychiatric clinics in India for treatment-resistant depression. It is extremely expensive (₹50,000 - ₹75,000 per session) and must be administered under direct psychiatric supervision.

---

3. Clinical Pharmacology: The NMDA Blockade

Mechanism of Action

Ketamine is a non-competitive NMDA receptor antagonist.

• The Glutamate Switch: It blocks the NMDA receptors, which are responsible for the transmission of excitatory glutamate signals.
• Dissociative State: By “disconnecting” the thalamus from the cerebral cortex, it creates a state where the brain receives sensory input but cannot process it. The patient is “awake” but does not perceive pain or their surroundings.
• The “Glutamate Burst”: At low doses (antidepressant doses), it triggers a cascade of glutamate release that helps “repair” damaged neural pathways, providing rapid relief from depression.

Pharmacokinetics

• Onset (Injection): 30 seconds (IV) to 3 minutes (IM).
• Duration: 30 to 60 minutes for the anesthetic effect; up to 2-3 hours for the “after-effects.”
• Metabolism: Primarily via the CYP2B6 and CYP3A4 enzymes into Norketamine, which also has mild anesthetic properties.

---

4. Euphoria and Misuse: The “K-Hole” Phenomenon

Euphoria Profile

• Low Dose (The “Wonky” Phase): Distorted perception of time and space, mild euphoria, and a feeling of “floating.”
• Medium Dose (The “Dissociative” Phase): Intense visual hallucinations, a feeling of “leaving the body,” and an inability to speak or move normally.
• High Dose (The “K-Hole”): A state of complete detachment from reality. Users describe it as “being a spirit in a void” or “witnessing the birth of the universe.” This state can be profoundly spiritual or terrifyingly traumatic.

Misuse Trends in India 2026

1. “Cooking” Liquid K: Illicit users procure medical vials (diverted from clinics or veterinary shops) and “cook” the liquid on a plate over steam to create a white powder for insufflation (snorting).
2. Techno/Rave Culture: In cities like Mumbai, Goa, and Bangalore, Ketamine is used as a “landing gear” to come down from stimulants like MDMA or Cocaine.
3. Drink Spiking: Because it is odorless and tasteless in liquid form, it remains a risk for drug-facilitated sexual assault, though the CDSCO has mandated bittering agents in some veterinary-grade vials to combat this.

---

5. Critical Risks: “K-Bladder” and Fatal Aspiration

A. Ketamine-Induced Cystitis (“K-Bladder”)

Chronic Ketamine use causes direct chemical damage to the lining of the bladder.

• The Symptoms: Excruciatingly painful urination, blood in the urine, and an “overactive bladder” (needing to pee every 10-15 minutes).
• The Permanent Damage: In advanced cases, the bladder shrinks and becomes scarred. Indian urologists have performed “Bladder Augmentation” surgeries on users as young as 22 due to irreversible K-bladder damage.

B. Aspiration Risk

Because Ketamine maintains the gag reflex but can cause vomiting, users who are in a “K-Hole” are at high risk of choking on their own vomit. This is a common cause of death when Ketamine is used alone and in high doses.

C. Flashbacks and Psychosis

Chronic use can lead to persistent “dissociative flashbacks” and a state of cognitive “slowness” that can last for weeks after the last dose.

---

6. Toxicity and Overdose

Overdose Signs

• Severe Nystagmus (Rapid, involuntary eye movements).
• Catatonia (Total inability to move or respond).
• Severe Hypertension and Tachycardia.
• Respiratory Arrest (rare but possible if combined with alcohol).

Emergency Action: Call 14446. There is no antidote for Ketamine. Emergency rooms provide airway management and sedation to control the “emergence delirium” as the drug wears off.

---

7. Addiction and Recovery

• Tolerance: Builds extremely rapidly. Users often find they need 5-10x their initial dose within weeks.
• Withdrawal: Characterized by intense “cravings,” anxiety, tremors, and a profound lack of motivation (“Anhedonia”).
• Recovery: Requires a combination of cognitive-behavioral therapy (CBT) and, in many cases, urological treatment for bladder damage.

Resources for Help in India

• National Drug De-addiction Helpline: 14446
• NIMHANS: Bangalore (Specialized Ketamine addiction research unit).
• SCARF India: Chennai (Psychiatric support for dissociative disorders).

---

8. Harm Reduction Strategies

• The “Recovery Position”: If someone is in a “K-Hole,” place them on their side (recovery position) to prevent choking if they vomit.
• Never Use Alone: Because of the dissociation, users cannot help themselves in an emergency.
• The “K-Bladder” Alert: If you feel any pain while urinating, STOP using Ketamine immediately. The damage is cumulative and often permanent.
• Avoid Alcohol: Combining Ketamine and Alcohol is a “death trap.” It massively increases the risk of fatal respiratory depression and choking.
• Hydration: Drink plenty of water and green tea, which some studies suggest may provide mild protection for the bladder lining.

---

Next in the Series: Part 32: Dextromethorphan – The Cough Syrup High and the ‘Plateau’ Effect

Disclaimer: This series is for educational and harm-reduction purposes only. Ketamine is a strictly controlled Schedule X/NDPS substance in India. Unauthorized use is illegal and carries severe health risks, including permanent organ damage.